Compare · DCT vs WGS
DCT vs WGS
Side-by-side comparison of Duck Creek Technologies Inc. (DCT) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DCT and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- DCT is the larger of the two at $3.16B, about 2.0x WGS ($1.55B).
- WGS has hit the wire 3 times in the past 4 weeks while DCT has been quiet.
- DCT has more recent analyst coverage (18 ratings vs 8 for WGS).
- Company
- Duck Creek Technologies Inc.
- GeneDx Holdings Corp.
- Price
- $19.00+0.00%
- $52.31-7.04%
- Market cap
- $3.16B
- $1.55B
- 1M return
- -
- +51.05%
- 1Y return
- -
- -27.76%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 3
- Recent ratings
- 18
- 8
Duck Creek Technologies Inc.
Duck Creek Technologies, Inc. provides software-as-a-service core systems to the property and casualty insurance industry in North America. It offers Duck Creek Policy, a full lifecycle solution for the development of products and quoting, binding, and servicing of policies across various channels from agents and brokers to end-users; Duck Creek Billing that provides payment and invoicing capabilities, such as billing and collections, commission processing, disbursement management, and general ledger capabilities for insurance lines and bill types; and Duck Creek Claims that supports the entire claims lifecycle from first notice of loss through investigation, payments, negotiations, reporting, and closure. The company also provides Duck Creek Rating that allows carriers to develop new rates and models and deliver accurate quotes in real-time based on the complex rating algorithms; Duck Creek Insights, an insurance analytics solution that allows carriers to gather and analyze data from internal and external sources and facilitate rapid analysis and reporting on a single system; Duck Creek Digital Engagement that offer digital interactions between property and casualty insurers and their agents, brokers, and policyholders; and Duck Creek Distribution Management that automates sales channel activities for agents and brokers, including producer onboarding, compliance, and compensation management. In addition, it offers Duck Creek Reinsurance Management that automates critical financial and administrative functions; and Duck Creek Industry Content that provides pre-built content, including base business rules, product designs, rating algorithms, data capture screens, and workflows for insurance lines of business. The company serves insurance carriers and leaders. Duck Creek Technologies, Inc. was founded in 2016 and is headquartered in Boston, Massachusetts.
Latest DCT
- SEC Form SC 13G/A filed by Duck Creek Technologies Inc. (Amendment)
- SEC Form SC 13G/A filed by Duck Creek Technologies Inc. (Amendment)
- Duck Creek Technologies achieves Dominant Provider status for its policy administration solution by Aite-Novarica
- SEC Form 15-12G filed by Duck Creek Technologies Inc.
- Duck Creek Technologies VP of Product Strategy and Co-Founder, Andy Yohn, to Present at the 2023 Verisk Insurance Conference
- One Duck Creek Summit to celebrate its efforts across connection, culture and community
- SEC Form SC 13D/A filed by Duck Creek Technologies Inc. (Amendment)
- SEC Form 4 filed by Winter Jeffrey Howard
- SEC Form 4 filed by Van Biert Eugene Jr.
- SEC Form 4 filed by Vaidyanathan Nageswaran
Latest WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)